It has been a really busy 48 hours for Louisiana. On Wednesday, the Supreme Courtroom determined Callis. The next day, the Governor introduced he would droop the upcoming main elections to permit the legislature to redistrict. There may be additionally litigation earlier than the Supreme Courtroom in regards to the issuance of the judgment in Callis. Earlier at the moment, the Governor was sued to enjoin the cancellation of the election.
And just some moments in the past, the Fifth Circuit panel granted a keep in Louisiana’s problem to the mifepristone telemedicine approval from 2023. What, you thought the case was over after Alliance for Hippocratic Medication? You haven’t been following the Fifth Circuit intently sufficient.
For now, I’ll simply paste the introduction of Decide Kyle Duncan’s panel opinion.
In Dobbs v. Jackson Girls’s Well being Group, 597 U.S. 215 (2022), the Supreme Courtroom returned the regulation of abortion to the states. In response, the Biden Administration directed federal companies to “develop entry to . . . treatment abortion.” Exec. Order No. 14076, 87 Fed. Reg. 42053 (July 8, 2022). The following 12 months, the Meals and Drug Administration (FDA) formally altered its security tips for the abortion drug mifepristone. Underneath the brand new regulation, the drug might now be prescribed on-line and allotted via the mail, with none want for an in-person go to to a health care provider. In 2025, Louisiana challenged the brand new regulation in federal court docket below the Administrative Process Act (APA). It argued that FDA’s justifications for remotely meting out mifepristone had been based mostly on flawed or nonexistent knowledge. It additionally documented how the brand new regulation had resulted in quite a few unlawful abortions in Louisiana and in Louisiana paying 1000’s in Medicaid payments for girls harmed by mifepristone. Louisiana sought a keep of the regulation whereas the litigation proceeded. In response, FDA conceded it had did not adequately examine whether or not remotely prescribing mifepristone is protected. However the company resisted staying the regulation, arguing it was within the midst of a complete evaluate of mifepristone protocols. The company, nevertheless, couldn’t say when that evaluate is likely to be full and admitted it was nonetheless accumulating knowledge. The district court docket agreed that Louisiana was more likely to win its problem to the mifepristone regulation and was struggling irreparable hurt from it. Nonetheless, the court docket declined to remain the regulation based mostly on its balancing of the equities and the general public curiosity. Louisiana appealed to our court docket and sought a keep pending enchantment below 5 U.S.C. § 705.
We grant the keep.
This case ought to get to the Supreme Courtroom ver quickly.
To be clear, this ruling wouldn’t take mifepristone off the market. However it will require individuals to have an in individual analysis earlier than receiving a prescription for the abortion drug. Put up-Dobbsthe variety of abortions nationwide has seemingly elevated, largely, due to the telemedicine requirement. Medical doctors in blue states ship these drugs to Louisiana, Texas, and different crimson states, and are protected by state protect legal guidelines. But when there may be an in-person requirement to prescribe the drug, these docs wouldn’t be capable of dispense throughout state strains.
The Trump Administration seemingly doesn’t need this headache. The federal government has raised a number of standing and different procedural defenses, however has not defended the Biden determination on the deserves. Let’s have a look at what SG Sauer does earlier than the Supreme Courtroom everybody.
